TANTALUS Therapy in Type 2 Diabetic Patients Intolerant or Inadequately Responsive to GLP-1 Receptor Agonist Therapy
Clinical trial NCT01303315 · TERMINATED
Trial details
- NCT number
- NCT01303315
- Sponsor
- MetaCure (USA), Inc.
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2011-07-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.